Medications for Treating Bulimia Nervosa
Fluoxetine (60 mg daily) is the first-line medication treatment for bulimia nervosa, as it is FDA-approved specifically for this condition and has demonstrated significant reduction in binge-eating and purging behaviors. 1
First-Line Pharmacotherapy
- Fluoxetine (Prozac)
- Dosage: 60 mg daily
- FDA-approved specifically for moderate to severe bulimia nervosa
- Efficacy established in 8-16 week clinical trials 1
- Demonstrated significant reduction in binge-eating episodes and vomiting compared to placebo 2
- Can maintain response for up to 52 weeks in patients who initially respond to treatment 1
Alternative Medication Options
When fluoxetine is not effective or not tolerated, consider:
Other SSRIs
- Sertraline has shown efficacy in reducing binge eating crises and purging behaviors 3
For Binge Eating Disorder (related condition)
- Lisdexamfetamine: FDA-approved for BED 4
- Naltrexone/bupropion: Helpful for food cravings or addictive eating behaviors 4
- Duloxetine: Modulates serotonergic and noradrenergic pathways involved in mood regulation and impulse control 4
- Topiramate: Effective for BED, though optimal dosing requires further study 4
Treatment Approach
Step 1: Initiate Medication
- Begin with fluoxetine 60 mg daily (higher dose is more effective than 20 mg daily) 2
- Monitor for common side effects: insomnia, nausea, asthenia, and tremor 2
Step 2: Combine with Psychotherapy
- Cognitive Behavioral Therapy (CBT) is recommended as first-line psychological treatment 4
- The combination of medication (particularly fluoxetine) and CBT is superior to medication alone 5
- Technology-based interventions such as internet/computer-guided CBT can be useful complements to treatment 4
Step 3: Monitor and Adjust
- Assess response after 8-12 weeks of treatment
- If inadequate response to initial medication, consider switching to another agent or adding CBT if not already implemented 6
- For patients who fail to respond to psychotherapy alone, adding fluoxetine (60 mg/day) can be effective 6
Important Considerations
- Regular monitoring is essential for patients with eating disorders, including weight, nutritional status, and eating behaviors 4
- Medication should be periodically reevaluated for long-term usefulness 1
- A multidisciplinary approach involving medical, psychiatric, psychological, and nutritional expertise yields optimal outcomes 4
Common Pitfalls to Avoid
- Underestimating the severity of the eating disorder
- Focusing solely on weight rather than normalizing eating behaviors
- Inadequate monitoring for medical complications
- Not addressing underlying psychological issues
- Premature discontinuation of medication in responders
Fluoxetine remains the gold standard pharmacological treatment for bulimia nervosa with the strongest evidence base and specific FDA approval for this indication.